| Geld/Brief | 21,76 $ / 70,55 $ |
| Spread | +224,22% |
| Schluss Vortag | 44,38 $ |
| Gehandelte Stücke | 0 |
| Tagesvolumen Vortag | 4.191.978 $ |
| Tagestief - Tageshoch - | |
| 52W-Tief 16,41 $ 52W-Hoch 48,15 $ | |
| Jahrestief 32,34 $ Jahreshoch 48,15 $ | |
| Umsatz in Mio. | - |
| Operatives Ergebnis (EBIT) in Mio. | -88,98 $ |
| Jahresüberschuss in Mio. | -75,27 $ |
| Umsatz je Aktie | - |
| Gewinn je Aktie | -1,88 $ |
| Gewinnrendite | - |
| Umsatzrendite | - |
| Return on Investment | -23,09% |
| Marktkapitalisierung in Mio. | 1.923 $ |
| KGV (Kurs/Gewinn) | -21,88 |
| KBV (Kurs/Buchwert) | 5,36 |
| KUV (Kurs/Umsatz) | - |
| Eigenkapitalrendite | - |
| Eigenkapitalquote | +94,13% |
| Handelsplatz | Letzter | Änderung | Vortag | Zeit | |
|---|---|---|---|---|---|
| AMEX | 44,64 $ | +0,20% | 44,55 $ | 16.07.26 | |
| Nasdaq | 45,20 $ | +1,85% | 44,38 $ | 16.07.26 | |
| NYSE | 46,12 $ | +3,52% | 44,55 $ | 16.07.26 | |
| Datum | Kurs | Volumen |
|---|---|---|
| 16.07.26 | 46,80 | 1,00 M |
| 15.07.26 | 44,38 | 2,82 M |
| 14.07.26 | 42,59 | 1,27 M |
| 13.07.26 | 43,95 | 1,69 M |
| 10.07.26 | 45,29 | 1,54 M |
| 09.07.26 | 44,94 | 2,14 M |
| Zeitraum | Kurs | % |
|---|---|---|
| 1 Woche | 44,94 $ | +4,14% |
| 1 Monat | 34,75 $ | +34,68% |
| 6 Monate | 39,11 $ | +19,66% |
| 1 Jahr | 18,49 $ | +153,11% |
| 5 Jahre | - | - |
| Marktkapitalisierung | 1,92 Mrd. $ |
| Streubesitz | 37,12% |
| Währung | USD |
| Land | USA |
| Sektor | Gesundheit |
| Branche | Biotechnologie |
| Aktientyp | Stammaktie |
| +21,94% | RA Capital Management, LLC |
| +14,94% | TPG GP A, LLC |
| +7,89% | Orbimed Advisors, LLC |
| +7,08% | Viking Global Investors LP |
| +6,63% | Atlas Venture Life Science Advisors, LLC |
| +5,49% | Enavate Sciences GP, LLC |
| +3,24% | JPMorgan Chase & Co |
| +3,21% | Jennison Associates LLC |
| +2,86% | BlackRock Inc |
| +2,62% | Vanguard Group Inc |
| +2,41% | Citadel Advisors Llc |
| +2,28% | Vanguard Capital Management, LLC |
| +2,15% | Deerfield Management Co |
| +1,87% | Vanguard Total Stock Mkt Idx Inv |
| +1,68% | T. Rowe Price Associates, Inc. |
| +1,67% | State Street Corp |
| +1,46% | Perceptive Advisors LLC |
| +1,44% | PGIM Jennison Health Sciences Z |
| +1,44% | Jennison Health Sciences Equity |
| +1,43% | Eventide Asset Management, LLC |
| +1,42% | Eventide Healthcare & Life Sciences I |
| +1,27% | T. Rowe Price Health Sciences |
| +1,25% | Aberdeen Group PLC |
| +1,22% | JPMorgan Small Cap Growth A |
| +1,00% | State Street® SPDR® S&P® Biotech ETF |
| +0,89% | Baker Bros Advisors LP |
| +0,87% | Kalehua Capital Management LLC |
| +0,86% | Geode Capital Management, LLC |
| +0,85% | iShares Russell 2000 ETF |
| +0,80% | JPM Global Healthcare C acc USD |
| +0,66% | Siren, L.L.C. |
| +0,52% | abrdn Healthcare Investors |
| +0,41% | iShares Biotechnology ETF |
| +0,39% | JPMorgan Small Cap Blend A |
| +0,36% | Vanguard Institutional Extnd Mkt Idx Tr |
| +0,35% | Fidelity Small Cap Index |
| +0,29% | iShares Russell 2000 Growth ETF |
| +0,27% | Heptagon Driehaus US Micro Cap Eq C$ Acc |
| +0,24% | Franklin Biotechnology Discv A(acc)USD |
| +0,22% | abrdn Life Sciences Investors |
| +0,22% | Russell 2000 Equity Index Fund B |
| +0,21% | State St Russell Sm/Mid Cp® Indx SL Cl I |
| +0,18% | Vanguard Russell 2000 ETF |
| +94,04% | Institutionelle Aktionäre |
| +37,12% | Streubesitz |
| -56,92% | Individuelle Aktionäre |